TRV GP II, LLC
- SEC CIK
- 0001614073
- Latest filing
- Nov 3, 2022
JNCE holding history
Jounce Therapeutics, Inc. in every 13F filed by TRV GP II, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNCE overviewAll 13F holders of JNCEFull Q3 2022 holdings
- Shares (Q3 2022)
- 572,829
- Value
- $1.34M
- % of portfolio
- 100.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 572,829 | $1.34M | 100.0% | −775,000−57.5% | Reduced | Holders |
| Q2 2022 | 1,347,829 | $4.08M | 88.5% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,347,829 | $9.15M | 93.4% | −1,350,000−50.0% | Reduced | Holders |
| Q4 2021 | 2,697,829 | $22.5M | 93.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,697,829 | $20.0M | 88.8% | −1,750,000−39.3% | Reduced | Holders |
| Q2 2021 | 4,447,829 | $30.2M | 89.3% | −2,052,520−31.6% | Reduced | Holders |
| Q1 2021 | 6,500,349 | $66.8M | 42.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.